Want to see DE:LIK full AI Analyst Report?

Limes Schlosskliniken AG (LIK) Price & Analysis

3 Followers

LIK Stock Chart & Stats

€360.00

€0.00(0.00%)

At close: Jan 08 4:00 PM EST

€360.00

€0.00(0.00%)

Day’s Range― - ―

52-Week Range€316.00 - €560.00

Previous CloseN/A

Volume7.00

Average Volume (3M)37.00

Market Cap

€163.50M

Enterprise Value€150.88M

Total Cash (Recent Filing)€10.31M

Total Debt (Recent Filing)€10.73M

Price to Earnings (P/E)28.3

Beta-0.06

Next Earnings

Aug 31, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)19.29

Shares Outstanding300,000

10 Day Avg. Volume27

30 Day Avg. Volume37

Financial Highlights & Ratios

PEG Ratio0.23

Price to Book (P/B)4.17

Price to Sales (P/S)2.11

P/FCF Ratio142.49

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)32.98

Revenue Forecast (FY)€66.40M

Bulls Say, Bears Say

Bulls Say

Sustained Revenue GrowthConsistent top-line expansion across multiple years demonstrates durable demand for LIK's specialist private clinic services. Strong revenue growth supports scale economics, improves bargaining power with suppliers, and provides capacity to reinvest in facilities and high-margin service lines over the medium term.

Consistent ProfitabilitySustained positive EBIT and multi-year net income show the business can convert revenues to operating profits. That profitability enables internal financing for targeted investments, supports a stronger equity base, and signals operational competence in managing high-end clinical services.

Improving Balance SheetMaterial equity growth and a lower debt-to-equity ratio reflect healthier capitalization and greater financial flexibility. Improved leverage reduces refinancing vulnerability, helps sustain capital investments in clinic infrastructure, and strengthens resilience to sector cyclicality over the coming months.

Bears Say

Uneven Free Cash FlowVolatile free cash flow undermines the company's ability to reliably fund capex, pay down debt, or return capital. Recurrent swings—negative in multiple years and weak conversion in 2024—suggest working-capital sensitivity or lumpy reinvestment, raising refinancing and operational planning risks.

Margin VolatilitySignificant swings in gross and net margins reduce earnings predictability and make long-term forecasting harder. Volatility may reflect case-mix, pricing sensitivity, or accounting/one-off effects, which can compress sustainable margins and challenge consistent cash generation as demand or input costs shift.

Meaningful Absolute Debt & Historical LeverageAlthough leverage metrics improved, the company still carries notable absolute debt which can constrain strategic flexibility. Past episodes of high leverage and negative profitability signal susceptibility to downturns, increasing the importance of stable cash flow to service obligations.

LIK FAQ

What was Limes Schlosskliniken AG’s price range in the past 12 months?

Limes Schlosskliniken AG lowest stock price was €316.00 and its highest was €560.00 in the past 12 months.

What is Limes Schlosskliniken AG’s market cap?

Limes Schlosskliniken AG’s market cap is €163.50M.

When is Limes Schlosskliniken AG’s upcoming earnings report date?

Limes Schlosskliniken AG’s upcoming earnings report date is Aug 31, 2026 which is in 60 days.

How were Limes Schlosskliniken AG’s earnings last quarter?

Limes Schlosskliniken AG released its earnings results on May 11, 2026. The company reported €7.993 earnings per share for the quarter, beating the consensus estimate of N/A by €7.993.

Is Limes Schlosskliniken AG overvalued?

According to Wall Street analysts Limes Schlosskliniken AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Limes Schlosskliniken AG pay dividends?

Limes Schlosskliniken AG pays a N/A dividend of €10 which represents an annual dividend yield of N/A. See more information on Limes Schlosskliniken AG dividends here

What is Limes Schlosskliniken AG’s EPS estimate?

Limes Schlosskliniken AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Limes Schlosskliniken AG have?

Limes Schlosskliniken AG has 300,000 shares outstanding.

What happened to Limes Schlosskliniken AG’s price movement after its last earnings report?

Limes Schlosskliniken AG reported an EPS of €7.993 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.225%.

Which hedge fund is a major shareholder of Limes Schlosskliniken AG?

Currently, no hedge funds are holding shares in DE:LIK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Limes Schlosskliniken AG Stock Smart Score

Neutral

Insider Transactions

Sold Shares

Worth €6.4M over
the Last 3 Months

Technicals

Fundamentals

Return on Equity

24.05%

Trailing 12-Months

Asset Growth

17.15%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Limes Schlosskliniken AG

LIMES Schlosskliniken AG oversees private healthcare facilities specializing in psychiatric, psychotherapeutic, and psychosomatic treatments. The organization primarily concentrates on addressing conditions arising from stress, alongside a variety of psychological and emotional disorders such as depression, severe burnout, mood disorders, and trauma. Headquartered in Cologne, Germany, LIMES Schlosskliniken AG operates as a subsidiary of GMF Capital GmbH.